首页 › 基金 › DME Capital Management, LP › IMVT
DME Capital Management, LP 对 IMVT 的持仓历史
IMMUNOVANT INC · 医疗保健
DME Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 IMVT(IMMUNOVANT INC)70,140 股,市值约 US$2.4M,约占其申报组合的 0.07%,在其申报持仓中市值排名第 42 位。 DME Capital Management, LP 最近 3 个申报季度中有 3 个季度披露了 IMVT 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
DME Capital Management, LP 对 IMVT 的持仓演变
DME Capital Management, LP 于 Q1 2026 首次披露 IMVT 持仓:93,520 股(约 US$2.3M)。 该持仓在 Q2 2026 达到峰值 93,520 股,市值约 US$3.6M。 在 3 次申报中,DME Capital Management, LP 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 70,140 股、市值约 US$2.4M,环比减持 -23,380 股。。 持仓曾出现大幅变动:Q3 2026 减持约 25% (随后一个季度股价下跌 1%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 93.52K | $2.32M | 新进 |
| Q2 2026 | 93.52K | $3.60M | 持有 |
| Q3 2026 | 70.14K | $2.37M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IMVT 与 13F 数据
IMVT(IMMUNOVANT INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 IMVT,申报仓位最大的包括:Deep Track Capital, LP (US$309.5M), 法拉龙资本管理 (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$218.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IMVT 的基金
- Deep Track Capital, LP 9.16M 股 · $309.45M · Q3 2026
- 法拉龙资本管理 5.80M 股 · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 6.47M 股 · $218.59M · Q3 2026
- Two Seas Capital LP 4.61M 股 · $155.82M · Q3 2026
- TCG Crossover Management, LLC 4.46M 股 · $150.59M · Q3 2026
- RTW INVESTMENTS, LP 3.18M 股 · $107.35M · Q3 2026
- BAKER BROS. ADVISORS LP 2.77M 股 · $93.58M · Q3 2026
- ADAR1 Capital Management, LLC 2.12M 股 · $71.46M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.62M 股 · $54.89M · Q3 2026
- Alpine Global Management, LLC 1.37M 股 · $46.26M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 624.05K 股 · $21.08M · Q3 2026
更多关于 DME Capital Management, LP
常见问题
How long has DME Capital Management, LP held IMVT?
DME Capital Management, LP has disclosed IMVT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is DME Capital Management, LP's current position in IMVT?
As of Q3 2026, DME Capital Management, LP holds 70.14K shares of IMVT (IMMUNOVANT INC), valued at $2.37M, representing 0.07% of its reported portfolio and ranking #42.
Has DME Capital Management, LP been buying or selling IMVT?
In the latest 13F filing (Q3 2026), DME Capital Management, LP reduced its position in IMVT. The position peaked in Q2 2026 at 93.52K shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.